This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schulte-Hermann, R. Articles by Bursch, W. Search for Related Content PubMed PubMed Citation Articles by Schulte-Hermann, R. Articles by Bursch, W.

DNA Synthesis, Apoptosis, and Phenotypic Expression as Determinants of Growth of Altered Foci in Rat Liver during Phenobarbital Promotion

Institut für Tumorbiologie-Krebsforschung der Universität Wien [R. S-H., W. B.] and Institut für Toxikologie und Pharmakologie der Philipps-Universität Marburg a.d.Lahn [I. T-T., G. B.]

Carcinogenesis was initiated in female rat liver by a single dose of N-nitrosomorpholine; subsequently phenobarbital (PB) was administered via the diet at a daily dose of 50 mg/kg body weight for up to 49 weeks. Subgroups of rats were left untreated after 10 or 28 weeks on PB. PB produced the following changes: (a) accelerated appearance of neoplastic nodules and hepatocellular carcinoma (from 28 weeks onwards); (b) phenotypic changes in altered foci such as a shift from clear to eosinophilic appearance, enhanced expression of -glutamyltranspeptidase and other markers, and more distinct borders from surrounding liver; (c) an increase in foci number; and (d) accelerated foci enlargement. The increase in foci number was found to be due to increased phenotypic expression of foci.

DNA synthesis was measured by [³H]thymidine labeling at multiple time points. The rate of DNA synthesis was always approximately 10-fold higher in foci than in surrounding liver tissue. Despite this, after N-nitrosomorpholine alone foci grew little before 18–24 weeks. Continuous treatment with PB did not produce a persistent further increase of DNA synthesis in foci, although it accelerated foci growth. Furthermore, at early stages small and larger foci showed similar DNA synthesis activity. These findings indicate that the rate of cell replication as measured by DNA synthesis is not the only determinant of the growth rate of foci. Further studies showed that foci with indistinct borders (reflecting weak expression of the altered phenotype) grew much less than foci with distinct borders; this was at least in part due to an increased rate of cell death by apoptosis found in foci with indistinct borders. In conclusion, besides cell replication, apoptosis and the extent of phenotypic expression (remodeling) determine the growth rate of foci. Foci with weak phenotypic expression predominated after N-nitrosomorpholine alone; in these, a high incidence of apoptosis counterbalanced cell replication. In contrast, during PB treatment foci with strong phenotypic expression predominated; in these, apoptotic activity was lower and the high replicative activity could manifest itself.

Finally, all effects of PB on foci were largely although not completely reversible upon cessation of treatment; as a result phenotypic expression declined, and "remodeling" foci with high apoptotic activity predominated again.

¹ To whom requests for reprints should be addressed, at Institute für Tumorbiologie-Krebsforschung, Borschkegasse 8a, A-1090 Wien, Austria.

Received 12/18/89. Revised 4/12/90.

This article has been cited by other articles:

				J. Groos, P. Bannasch, M. Schwarz, and A. Kopp-Schneider Comparison of Mode of Action of Four Hepatocarcinogens: A Model-Based Approach Toxicol. Sci., October 1, 2007; 99(2): 446 - 454. [Abstract] [Full Text] [PDF]

				R. A. Roberts, P. E. Ganey, C. Ju, L. M. Kamendulis, I. Rusyn, and J. E. Klaunig Role of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis Toxicol. Sci., March 1, 2007; 96(1): 2 - 15. [Abstract] [Full Text] [PDF]

				J. M. Phillips, Y. Yamamoto, M. Negishi, R. R. Maronpot, and J. I. Goodman Orphan Nuclear Receptor Constitutive Active/Androstane Receptor-Mediated Alterations in DNA Methylation during Phenobarbital Promotion of Liver Tumorigenesis Toxicol. Sci., March 1, 2007; 96(1): 72 - 82. [Abstract] [Full Text] [PDF]

				J. Ding, X. Zhang, J. Li, L. Song, W. Ouyang, D. Zhang, C. Xue, M. Costa, J. A. Melendez, and C. Huang Nickel Compounds Render Anti-apoptotic Effect to Human Bronchial Epithelial Beas-2B Cells by Induction of Cyclooxygenase-2 through an IKKbeta/p65-dependent and IKK{alpha}- and p50-independent Pathway J. Biol. Chem., December 22, 2006; 281(51): 39022 - 39032. [Abstract] [Full Text] [PDF]

				A. N. Bachman, G. M. Curtin, D. J. Doolittle, and J. I. Goodman Altered Methylation in Gene-Specific and GC-Rich Regions of DNA Is Progressive and Nonrandom during Promotion of Skin Tumorigenesis Toxicol. Sci., June 1, 2006; 91(2): 406 - 418. [Abstract] [Full Text] [PDF]

				T. P. Ong, R. Heidor, A. de Conti, M. L. Z. Dagli, and F. S. Moreno Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase Carcinogenesis, June 1, 2006; 27(6): 1194 - 1203. [Abstract] [Full Text] [PDF]

				E. M. de Almeida Vasconcelos Fonseca, C. E. A. Chagas, R. P. Mazzantini, R. Heidor, T. P. Ong, and F. S. Moreno All-trans and 9-cis retinoic acids, retinol and {beta}-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage Carcinogenesis, November 1, 2005; 26(11): 1940 - 1946. [Abstract] [Full Text] [PDF]

				R. de Moura Espindola, R. P. Mazzantini, T. P. Ong, A. de Conti, R. Heidor, and F. S. Moreno Geranylgeraniol and {beta}-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-{kappa}B activation Carcinogenesis, June 1, 2005; 26(6): 1091 - 1099. [Abstract] [Full Text] [PDF]

				W. Bursch, M. Chabicovsky, U. Wastl, B. Grasl-Kraupp, K. Bukowska, H. Taper, and R. Schulte-Hermann Apoptosis in Stages of Mouse Hepatocarcinogenesis: Failure to Counterbalance Cell Proliferation and to Account for Strain Differences in Tumor Susceptibility Toxicol. Sci., May 1, 2005; 85(1): 515 - 529. [Abstract] [Full Text] [PDF]

				R. E. Watson, G. M. Curtin, D. J. Doolittle, and J. I. Goodman Progressive Alterations in Global and GC-Rich DNA Methylation during Tumorigenesis Toxicol. Sci., October 1, 2003; 75(2): 289 - 299. [Abstract] [Full Text] [PDF]

				S. Loeppen, D. Schneider, F. Gaunitz, R. Gebhardt, R. Kurek, A. Buchmann, and M. Schwarz Overexpression of Glutamine Synthetase Is Associated with {beta}-Catenin-Mutations in Mouse Liver Tumors during Promotion of Hepatocarcinogenesis by Phenobarbital Cancer Res., October 15, 2002; 62(20): 5685 - 5688. [Abstract] [Full Text] [PDF]

				A. Kinoshita, H. Wanibuchi, S. Imaoka, M. Ogawa, C. Masuda, K. Morimura, Y. Funae, and S. Fukushima Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21WAF1/Cip1, cyclin D1 and Ogg1 Carcinogenesis, February 1, 2002; 23(2): 341 - 349. [Abstract] [Full Text] [PDF]

				G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF]

				K. Hufnagl, W. Parzefall, B. Marian, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp Role of transforming growth factor {alpha} and prostaglandins in preferential growth of preneoplastic rat hepatocytes Carcinogenesis, August 1, 2001; 22(8): 1247 - 1256. [Abstract] [Full Text] [PDF]

				W. K. Kaufmann, C. I. Behe, V. M. Golubovskaya, L. L. Byrd, C. D. Albright, K. M. Borchet, S. C. Presnell, W. B. Coleman, J. W. Grisham, and G. J. Smith Aberrant cell cycle checkpoint function in transformed hepatocytes and WB-F344 hepatic epithelial stem-like cells Carcinogenesis, August 1, 2001; 22(8): 1257 - 1269. [Abstract] [Full Text] [PDF]

				J E Klaunig, L M Kamendulis, and Y. Xu Epigenetic mechanisms of chemical carcinogenesis Human and Experimental Toxicology, October 1, 2000; 19(10): 543 - 555. [Abstract] [PDF]

				A. Low-Baselli, W. W. Huber, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note Carcinogenesis, October 1, 2000; 21(10): 1869 - 1877. [Abstract] [Full Text] [PDF]

				M. Haag-Gronlund, R. Conolly, G. Scheu, L. Warngard, and R. Fransson-Steen Analysis of Rat Liver Foci Growth with a Quantitative Two-Cell Model after Treatment with 2,4,5,3',4'-Pentachlorobiphenyl Toxicol. Sci., September 1, 2000; 57(1): 32 - 42. [Abstract] [Full Text] [PDF]

				F. J. Elcock, E. Deag, R. A. Roberts, and J. K. Chipman Nafenopin Causes Protein Kinase C-Mediated Serine Phosphorylation and Loss of Function of Connexin 32 Protein in Rat Hepatocytes without Aberrant Expression or Localization Toxicol. Sci., July 1, 2000; 56(1): 86 - 94. [Abstract] [Full Text] [PDF]

				B. Grasl-Kraupp, G. Luebeck, A. Wagner, A. Low-Baselli, M. de Gunst, T. Waldhor, S. Moolgavkar, and R. Schulte-Hermann Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis) Carcinogenesis, July 1, 2000; 21(7): 1411 - 1421. [Abstract] [Full Text] [PDF]

				J. Chen, M. Gokhale, B. Schofield, S. Odwin, and J. D. Yager Inhibition of TGF-{beta}-induced apoptosis by ethinyl estradiol in cultured, precision cut rat liver slices and hepatocytes Carcinogenesis, June 1, 2000; 21(6): 1205 - 1211. [Abstract] [Full Text] [PDF]

				L. Klotz, H. J. Hacker, D. Klingmuller, P. Bannasch, U. Pfeifer, and F. Dombrowski Hepatocellular Alterations after Intraportal Transplantation of Ovarian Tissue in Ovariectomized Rats Am. J. Pathol., May 1, 2000; 156(5): 1613 - 1626. [Abstract] [Full Text] [PDF]

				N. Finnberg, U. Stenius, and J. Hogberg Xenobiotics Modulate the p53 Response to DNA Damage in Preneoplastic Enzyme-Altered Foci in Rat Liver; Effects of Diethylnitrosamine and Phenobarbital Toxicol. Sci., March 1, 2000; 54(1): 95 - 103. [Abstract] [Full Text] [PDF]

				S. Frey, A. Buchmann, W. Bursch, R. Schulte-Hermann, and M. Schwarz Suppression of apoptosis in C3H mouse liver tumors by activated Ha-ras oncogene Carcinogenesis, February 1, 2000; 21(2): 161 - 166. [Abstract] [Full Text] [PDF]

				E. I. Salim, H. Wanibuchi, K. Morimura, S. Kim, Y. Yano, S. Yamamoto, and S. Fukushima Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine Carcinogenesis, February 1, 2000; 21(2): 195 - 203. [Abstract] [Full Text] [PDF]

				A. Low-Baselli, K. Hufnagl, W. Parzefall, R. Schulte-Hermann, and B. Grasl-Kraupp Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis Carcinogenesis, January 1, 2000; 21(1): 79 - 86. [Abstract] [Full Text] [PDF]

				F. Dombrowski, L. Klotz, H. J. Hacker, Y. Li, D. Klingmuller, K. Brix, V. Herzog, and P. Bannasch Hyperproliferative Hepatocellular Alterations after Intraportal Transplantation of Thyroid Follicles Am. J. Pathol., January 1, 2000; 156(1): 99 - 113. [Abstract] [Full Text] [PDF]

				J. G. Christensen, E. H. Romach, L. N. Healy, A. J. Gonzales, S. P. Anderson, D. E. Malarkey, J. C. Corton, T. R. Fox, R. C. Cattley, and T. L. Goldsworthy Altered bcl-2 family expression during non-genotoxic hepatocarcinogenesis in mice Carcinogenesis, August 1, 1999; 20(8): 1583 - 1590. [Abstract] [Full Text] [PDF]

				G. A. Wood, D. S.R. Sarma, and M. C. Archer Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats Carcinogenesis, July 1, 1999; 20(7): 1169 - 1175. [Abstract] [Full Text] [PDF]

				F. Tombolan, D. Renault, D. Brault, M. Guffroy, F. Perin, and V. Thybaud Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of MutaTMMice treated with 5,9-dimethyldibenzo[c,g]carbazole Carcinogenesis, July 1, 1999; 20(7): 1357 - 1362. [Abstract] [Full Text] [PDF]

				C. Huang, W.-y. Ma, A. Goranson, and Z. Dong Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway Carcinogenesis, February 1, 1999; 20(2): 237 - 242. [Abstract] [Full Text] [PDF]

				S. Sanders and S. S. Thorgeirsson Phenobarbital promotes liver growth in c-myc/TGF-{alpha} transgenic mice by inducing hypertrophy and inhibiting apoptosis Carcinogenesis, January 1, 1999; 20(1): 41 - 49. [Abstract] [Full Text] [PDF]

				H. C. Pitot The Progression of Neoplasia, Cell Replication, and Electromagnetic Fields International Journal of Toxicology, January 1, 1998; 17(3_suppl): 59 - 108. [PDF]

				S. M. Cohen Cell Proliferation in the Evaluation of Carcinogenic Risk and the Inadequacies of the Initiation-Promotion Model International Journal of Toxicology, January 1, 1998; 17(3_suppl): 129 - 142. [PDF]

				R. Schulte-Hermann, W. Bursch, B. Grasl-Kraupp, B. Marian, L. Torok, P. Kahl-Rainer, and A. Ellinger Concepts of Cell Death and Application to Carcinogenesis Toxicol Pathol, January 1, 1997; 25(1): 89 - 93. [Abstract] [PDF]

				A. A. Constan, S. A. Benjamin, J. D. Tessari, D. C. Baker, and R. S.H. Yang Increased Rate of Apoptosis Correlates with Hepatocellular Proliferation in Fischer-344 Rats Following Long-Term Exposure to a Mixture of Groundwater Contaminants Toxicol Pathol, May 1, 1996; 24(3): 315 - 322. [Abstract] [PDF]

				J.K. Chipman Connexin genes as tumour suppressor genes? Altered homologous and heterologous gap-junc tional intercellular communication in primary human liver tumors associated with aberrant pro tein localization but not gene mutation of connexin 32. Krutovskikh V, Mazzoleni G, Mironov N, Omori Y, Aguelon A-M, Mesnil M, Berger F, Partensky C and Yamasaki H. International Journal of Cancer: 1994; 56: 87-94 Human and Experimental Toxicology, June 1, 1995; 14(6): 539 - 540. [PDF]

				F Oberhammer, G Fritsch, M Schmied, M Pavelka, D Printz, T Purchio, H Lassmann, and R Schulte-Hermann Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease J. Cell Sci., January 2, 1993; 104(2): 317 - 326. [Abstract] [PDF]